Abstract
The mouse has proven to be an excellent model for testing apolipoprotein mimetic peptides as agents to treat a variety of vascular inflammatory conditions including atherosclerosis, cognitive dysfunction associated with arteriole inflammation, chronic rejection of transplanted hearts, and scleroderma. The mechanism of action appears to relate to the ability of these peptides to preferentially bind pro-inflammatory oxidized lipids and is independent of the chirality of the peptides since peptides synthesized from either D- or L-amino acids appear to be equally effective.
Current Drug Targets
Title: Apo A-1 Mimetic Peptides as Atheroprotective Agents in Murine Models
Volume: 9 Issue: 3
Author(s): Mohamad Navab, G. M. Anantharamaiah, Srinivasa T. Reddy, Brian J. Van Lenten and Alan M. Fogelman
Affiliation:
Abstract: The mouse has proven to be an excellent model for testing apolipoprotein mimetic peptides as agents to treat a variety of vascular inflammatory conditions including atherosclerosis, cognitive dysfunction associated with arteriole inflammation, chronic rejection of transplanted hearts, and scleroderma. The mechanism of action appears to relate to the ability of these peptides to preferentially bind pro-inflammatory oxidized lipids and is independent of the chirality of the peptides since peptides synthesized from either D- or L-amino acids appear to be equally effective.
Export Options
About this article
Cite this article as:
Navab Mohamad, Anantharamaiah M. G., Reddy T. Srinivasa, Van Lenten J. Brian and Fogelman M. Alan, Apo A-1 Mimetic Peptides as Atheroprotective Agents in Murine Models, Current Drug Targets 2008; 9 (3) . https://dx.doi.org/10.2174/138945008783755584
DOI https://dx.doi.org/10.2174/138945008783755584 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
RNA Molecules in the Treatment of Human Diseases
Messenger and non-coding RNAs, including long and small transcripts, are mediators of gene expression. Gene expression at the RNA level shows significant aberrations in human diseases, including cancer, leukemia, lymphoma, cardiovascular diseases, and neurological disorders. Human transcripts serve either as biomarkers of diagnosis, prognosis, prediction of treatment response and/or therapy ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Endothelial Cells in Inflammation and Angiogenesis
Current Drug Targets - Inflammation & Allergy Cardioprotective Properties of HDL: Structural and Functional Considerations
Current Medicinal Chemistry Patent Annotations
Recent Patents on Anti-Infective Drug Discovery Digital Ulcers in Systemic Sclerosis – How to Manage in 2013?
Current Rheumatology Reviews Functional Role of Glycosphingolipids in Cancer
Current Medicinal Chemistry Pharmacologic Treatment of Pulmonary Arterial Hypertension
Current Pharmaceutical Design Gastrointestinal Disturbances in Anorexia Nervosa and Bulimia Nervosa
Current Drug Targets - CNS & Neurological Disorders Smad-Signaling in Mammary Gland Development and Tumorigenesis
Current Signal Transduction Therapy Impact of Immunogenetic Polymorphisms in Bone Marrow Failure Syndromes
Mini-Reviews in Medicinal Chemistry Sexual Dysfunction among Women with Connective Tissue Disease
Current Rheumatology Reviews Arthropathy in Patients with CREST Variant Scleroderma
Current Rheumatology Reviews Anti-Arthritic Effects of Immunomodulatory Peptide Injected in Joints
Current Drug Delivery Targeting Serine Proteases in Asthma
Current Topics in Medicinal Chemistry New Developments In Treatment After Lung Transplantation
Current Pharmaceutical Design Characteristics of Animal Models for Scleroderma
Current Rheumatology Reviews Energetic Metabolic Roles in Pulmonary Arterial Hypertension and Right Ventricular Remodeling
Current Pharmaceutical Design Insights on Biology and Pathology of HIF-1α/-2α, TGFβ/BMP, Wnt/β-Catenin, and NF-κB Pathways in Osteoarthritis
Current Pharmaceutical Design Editorial [Hot topic: Interstitial Lung Disease with Connective Tissue Diseases (Guest Editor: Eric Matteson)]
Current Rheumatology Reviews Transforming Growth Factor-β (TGF-β ) and its Role in the Pathogenesis of Systemic Sclerosis: A Novel Target for Therapy?
Recent Patents on Inflammation & Allergy Drug Discovery Pulmonary Hypertension: Current Therapy and Future Prospects
Cardiovascular & Hematological Agents in Medicinal Chemistry